224 related articles for article (PubMed ID: 9670851)
1. Ex vivo malignant glioma cells are sensitive to Fas (CD95/APO-1) ligand-mediated apoptosis.
Frei K; Ambar B; Adachi N; Yonekawa Y; Fontana A
J Neuroimmunol; 1998 Jul; 87(1-2):105-13. PubMed ID: 9670851
[TBL] [Abstract][Full Text] [Related]
2. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
3. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
Weller M; Frei K; Groscurth P; Krammer PH; Yonekawa Y; Fontana A
J Clin Invest; 1994 Sep; 94(3):954-64. PubMed ID: 7521890
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction.
Riffkin CD; Gray AZ; Hawkins CJ; Chow CW; Ashley DM
Neuro Oncol; 2001 Oct; 3(4):229-40. PubMed ID: 11584892
[TBL] [Abstract][Full Text] [Related]
5. Human astrocytomas co-expressing Fas and Fas ligand also produce TGFbeta2 and Bcl-2.
Frankel B; Longo SL; Ryken TC
J Neurooncol; 1999; 44(3):205-12. PubMed ID: 10720200
[TBL] [Abstract][Full Text] [Related]
6. Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo.
Rensing-Ehl A; Frei K; Flury R; Matiba B; Mariani SM; Weller M; Aebischer P; Krammer PH; Fontana A
Eur J Immunol; 1995 Aug; 25(8):2253-8. PubMed ID: 7545115
[TBL] [Abstract][Full Text] [Related]
7. Tumor Fas (APO-1/CD95) up-regulation results in increased apoptosis and survival times for rats with intracranial malignant gliomas.
Frankel B; Longo SL; Kyle M; Canute GW; Ryken TC
Neurosurgery; 2001 Jul; 49(1):168-75; discussion 175-6. PubMed ID: 11440439
[TBL] [Abstract][Full Text] [Related]
8. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.
Weller M; Malipiero U; Aguzzi A; Reed JC; Fontana A
J Clin Invest; 1995 Jun; 95(6):2633-43. PubMed ID: 7539458
[TBL] [Abstract][Full Text] [Related]
9. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation.
Shinohara H; Yagita H; Ikawa Y; Oyaizu N
Cancer Res; 2000 Mar; 60(6):1766-72. PubMed ID: 10749152
[TBL] [Abstract][Full Text] [Related]
10. Glioma apoptosis induced by macrophages involves both death receptor-dependent and independent pathways.
Chen GG; Chak EC; Chun YS; Lam IK; Sin FL; Leung BC; Ng HK; Poon WS
J Lab Clin Med; 2003 Mar; 141(3):190-9. PubMed ID: 12624600
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand.
von Bernstorff W; Spanjaard RA; Chan AK; Lockhart DC; Sadanaga N; Wood I; Peiper M; Goedegebuure PS; Eberlein TJ
Surgery; 1999 Jan; 125(1):73-84. PubMed ID: 9889801
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between tumor cells and neutrophils through the Fas (APO-1, CD95)/FasL system: human glioma cells enhance cell viability and stimulate cytokine production in neutrophils.
Hor WS; Huang WL; Lin YS; Yang BC
J Leukoc Biol; 2003 Mar; 73(3):363-8. PubMed ID: 12629150
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy.
Sata M; Suhara T; Walsh K
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):309-16. PubMed ID: 10669625
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibitors induce Fas-mediated apoptosis by c-Myc accumulation and subsequent induction of FasL message in human glioma cells.
Tani E; Kitagawa H; Ikemoto H; Matsumoto T
FEBS Lett; 2001 Aug; 504(1-2):53-8. PubMed ID: 11522296
[TBL] [Abstract][Full Text] [Related]
15. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
[TBL] [Abstract][Full Text] [Related]
16. Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells.
Knight MJ; Riffkin CD; Muscat AM; Ashley DM; Hawkins CJ
Oncogene; 2001 Sep; 20(41):5789-98. PubMed ID: 11593384
[TBL] [Abstract][Full Text] [Related]
17. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis in glioma cells by recombinant human Fas ligand.
Kawaguchi S; Mineta T; Ichinose M; Masuoka J; Shiraishi T; Tabuchi K
Neurosurgery; 2000 Feb; 46(2):431-8; discussion 438-9. PubMed ID: 10690733
[TBL] [Abstract][Full Text] [Related]
19. Effects of interferon-gamma and tumour necrosis factor-alpha on CD95/Fas ligand-mediated apoptosis in human blood eosinophils.
Luttmann W; Dauer E; Schmidt S; Marx O; Hossfeld M; Matthys H; Virchow JC
Scand J Immunol; 2000 Jan; 51(1):54-9. PubMed ID: 10632976
[TBL] [Abstract][Full Text] [Related]
20. Fas/APO-1 gene transfer for human malignant glioma.
Weller M; Malipiero U; Rensing-Ehl A; Barr PJ; Fontana A
Cancer Res; 1995 Jul; 55(13):2936-44. PubMed ID: 7540953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]